Veli YAZISIZ (2020) “Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment”, Archives of Rheumatology, 35(2), pp. 300–302. doi: 10.46497/ArchRheumatol.2020.7555.